High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban

A. N. Bonde; T. Martinussen; C. Y. Lee; J. Bhattacharya; G. Y. H. Lip; L. Staerk; G. Gislason; C. Torp-Pedersen; J. B. Olesen; M. Hlatky

doi:10.1093/eurheartj/ehz745.1155

High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban

A. N. Bonde, T. Martinussen, C. Y. Lee, J. Bhattacharya, G. Y. H. Lip, L. Staerk, G. Gislason, C. Torp-Pedersen, J. B. Olesen, M. Hlatky

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	P4779
Journal	European Heart Journal
Volume	40
Issue number	Supplement 1
Pages (from-to)	2983
Number of pages	1
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehz745.1155
Publication status	Published - 2019

Access to Document

10.1093/eurheartj/ehz745.1155

Cite this

Bonde, A. N., Martinussen, T., Lee, C. Y., Bhattacharya, J., Lip, G. Y. H., Staerk, L., Gislason, G., Torp-Pedersen, C., Olesen, J. B., & Hlatky, M. (2019). High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. European Heart Journal, 40(Supplement 1), 2983. [P4779]. https://doi.org/10.1093/eurheartj/ehz745.1155

High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. / Bonde, A. N.; Martinussen, T.; Lee, C. Y.; Bhattacharya, J.; Lip, G. Y. H.; Staerk, L.; Gislason, G.; Torp-Pedersen, C.; Olesen, J. B.; Hlatky, M.

In: European Heart Journal, Vol. 40, No. Supplement 1, P4779, 2019, p. 2983.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Bonde, AN, Martinussen, T, Lee, CY, Bhattacharya, J, Lip, GYH, Staerk, L, Gislason, G, Torp-Pedersen, C, Olesen, JB & Hlatky, M 2019, 'High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban', European Heart Journal, vol. 40, no. Supplement 1, P4779, pp. 2983. https://doi.org/10.1093/eurheartj/ehz745.1155

Bonde, A. N. ; Martinussen, T. ; Lee, C. Y. ; Bhattacharya, J. ; Lip, G. Y. H. ; Staerk, L. ; Gislason, G. ; Torp-Pedersen, C. ; Olesen, J. B. ; Hlatky, M. / High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. In: European Heart Journal. 2019 ; Vol. 40, No. Supplement 1. pp. 2983.

@article{43c55d6313d6480f8573fbe6d711a614,

title = "High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban",

author = "Bonde, {A. N.} and T. Martinussen and Lee, {C. Y.} and J. Bhattacharya and Lip, {G. Y. H.} and L. Staerk and G. Gislason and C. Torp-Pedersen and Olesen, {J. B.} and M. Hlatky",

year = "2019",

doi = "10.1093/eurheartj/ehz745.1155",

language = "English",

volume = "40",

pages = "2983",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Supplement 1",

}

TY - ABST

T1 - High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban

AU - Bonde, A. N.

AU - Martinussen, T.

AU - Lee, C. Y.

AU - Bhattacharya, J.

AU - Lip, G. Y. H.

AU - Staerk, L.

AU - Gislason, G.

AU - Torp-Pedersen, C.

AU - Olesen, J. B.

AU - Hlatky, M.

PY - 2019

Y1 - 2019

U2 - 10.1093/eurheartj/ehz745.1155

DO - 10.1093/eurheartj/ehz745.1155

M3 - Conference abstract in journal

VL - 40

SP - 2983

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - Supplement 1

M1 - P4779

ER -